affiliation not provided to SSRN
Endometrial cancerCost-effectivenessDostarlimabTrastuzumabHER2Mismatch repair (MMR)
endometrial cancer, Next-generation sequencing, Molecular profiling, Cost-effectiveness
endometrial cancer, postmenopausal bleeding, transvaginal ultrasound, endometrial thickness, endometrial visualization